Accumulation of STIM1 is associated with the degenerative muscle fibre phenotype in ALS and other neurogenic atrophies

Neuropathology and Applied Neurobiology

Volumn 41, Issue 3, 2015, Pages 304-318

  Goswami, Anand ^a   Jesse, Christofer Marvin ^a   Chandrasekar, Akila ^a   Bushuven, Eva ^a   Vollrath, Jan Tilmann ^a   Dreser, Alice ^a   Katona, Istvan ^a   Beyer, Cordian ^a   Johann, Sonja ^a   Feller, A C ^b   Grond, M ^c   Wagner, S ^c   Nikolin, Stefan ^a   Troost, Dirk ^d   Weis, Joachim ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Hospital Siegen   (Germany)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ALS; Calcium homeostasis; Denervation; Neurogenic muscular atrophy; STIM1; Tubular aggregate myopathy

Indexed keywords

ESTERASE; RYANODINE RECEPTOR; STROMAL INTERACTION MOLECULE 1; SYNAPTOBREVIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; VESICLE ASSOCIATED MEMBRANE PROTEIN B; MEMBRANE PROTEIN; STIM1 PROTEIN, HUMAN; TUMOR PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CELL SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE TISSUE; MUSCLE TYPE ACCORDING TO FUNCTION; MUTATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; SOLEUS MUSCLE; TISSUE STRUCTURE; ANIMAL; DISEASE MODEL; METABOLISM; PATHOLOGY; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE, SKELETAL; MUSCULAR ATROPHY; NEOPLASM PROTEINS; PHENOTYPE;

EID: 84924063064     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/nan.12164     Document Type: Article

References (64)

1. Henderson CE, Bloch-Gallego E, Camu W, Gouin A, Lemeulle C, Mettling C. Motoneuron survival factors: biological roles and therapeutic potential. Neuromuscul Disord 1993; 3: 455-458
2. Henderson CE, Camu W, Mettling C, Gouin A, Poulsen K, Karihaloo M, Rullamas J, Evans T, McMahon SB, Armanini MP, Berkemeier L, Phillips H, Rosenthal A. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 1993; 363: 266-270
3. Henderson CE, Huchet M, Changeux JP. Denervation increases a neurite-promoting activity in extracts of skeletal muscle. Nature 1983; 302: 609-611
4. Gates HJ, Ridge RM. The importance of competition between motoneurones in developing rat muscle; effects of partial denervation at birth. J Physiol 1992; 445: 457-472
5. Funk F, Ceuterick-de Groote C, Martin JJ, Meinhardt A, Taratuto AL, De Bleecker J, Van Coster R, De Paepe B, Schara U, Vorgerd M, Hausler M, Koppi S, Maschke M, De Jonghe P, Van Maldergem L, Noel S, Zimmermann CW, Wirth S, Isenmann S, Stadler R, Schroder JM, Schulz JB, Weis J, Claeys KG. Morphological spectrum and clinical features of myopathies with tubular aggregates. Histol Histopathol 2013; 28: 1041-1054
6. Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech 2013; 6: 25-39
7. Dadon-Nachum M, Melamed E, Offen D. The 'dying-back' phenomenon of motor neurons in ALS. J Mol Neurosci 2011; 43: 470-477
8. Glass DJ. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 2003; 5: 87-90
9. Kato S. Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol 2008; 115: 97-114
10. Kim WK, Liu X, Sandner J, Pasmantier M, Andrews J, Rowland LP, Mitsumoto H. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology 2009 Nov 17; 73: 1686-1692
11. Sandri M. Signaling in muscle atrophy and hypertrophy. Physiology 2008; 23: 160-170
12. Chang HC, Dimlich DN, Yokokura T, Mukherjee A, Kankel MW, Sen A, Sridhar V, Fulga TA, Hart AC, Van Vactor D, Artavanis-Tsakonas S. Modeling spinal muscular atrophy in Drosophila. PLoS ONE 2008; 3: e3209
13. Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, Robins DM, Lieberman AP. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest 2006 Oct; 116: 2663-2672
14. Chevalier-Larsen ES, O'Brien CJ, Wang H, Jenkins SC, Holder L, Lieberman AP, Merry DE. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci 2004; 24: 4778-4786
15. Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, Sang C, Kobayashi Y, Doyu M, Sobue G. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 2002; 35: 843-854
16. Jordan CL, Lieberman AP. Spinal and bulbar muscular atrophy: a motoneuron or muscle disease? Curr Opin Pharmacol 2008; 8: 752-758
17. Deforges S, Branchu J, Biondi O, Grondard C, Pariset C, Lecolle S, Lopes P, Vidal PP, Chanoine C, Charbonnier F. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol 2009; 587: 3561-3572
18. Grondard C, Biondi O, Armand AS, Lecolle S, Della Gaspera B, Pariset C, Li H, Gallien CL, Vidal PP, Chanoine C, Charbonnier F. Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. J Neurosci 2005; 25: 7615-7622
19. Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol 2003; 53: 804-807
20. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006; 312: 1389-1392
21. Dupuis L, Echaniz-Laguna A. Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments. Curr Drug Targets 2010; 11: 1250-1261
22. Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998; 24: 104-117
23. Julien JP. Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded. Cell 2001; 104: 581-591
24. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004; 10: S10-17
25. Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science 2002; 296: 1991-1995
26. De Vos KJ, Morotz GM, Stoica R, Tudor EL, Lau KF, Ackerley S, Warley A, Shaw CE, Miller CC. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum Mol Genet 2012; 21: 1299-1311
27. Shaw PJ, Ince PG. Glutamate, excitotoxicity and amyotrophic lateral sclerosis. J Neurol 1997; 244: S3-14
28. Zhou J, Yi J, Fu R, Liu E, Siddique T, Rios E, Deng HX. Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis. J Biol Chem 2010; 285: 705-712
29. Prause J, Goswami A, Katona I, Roos A, Schnizler M, Bushuven E, Dreier A, Buchkremer S, Johann S, Beyer C, Deschauer M, Troost D, Weis J. Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis. Hum Mol Genet 2013; 22: 1581-1600
30. Ruiz R, Casanas JJ, Torres-Benito L, Cano R, Tabares L. Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice. J Neurosci 2010; 30: 849-857
31. Dunn SE, Simard AR, Prud'homme RA, Michel RN. Calcineurin and skeletal muscle growth. Nat Cell Biol 2002; 4: author reply E46-7
32. Launikonis BS, Murphy RM, Edwards JN. Toward the roles of store-operated Ca2+ entry in skeletal muscle. Pflugers Arch 2010; 460: 813-823
33. Liou J, Kim ML, Heo WD, Jones JT, Myers JW, Ferrell JE Jr, Meyer T. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol 2005; 15: 1235-1241
34. Stathopulos PB, Zheng L, Li GY, Plevin MJ, Ikura M. Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry. Cell 2008; 135: 110-122
35. Yang X, Jin H, Cai X, Li S, Shen Y. Structural and mechanistic insights into the activation of Stromal interaction molecule 1 (STIM1). Proc Natl Acad Sci U S A 2012; 109: 5657-5662
36. Darbellay B, Arnaudeau S, Konig S, Jousset H, Bader C, Demaurex N, Bernheim L. STIM1- and Orai1-dependent store-operated calcium entry regulates human myoblast differentiation. J Biol Chem 2009; 284: 5370-5380
37. Mancarella S, Potireddy S, Wang Y, Gao H, Gandhirajan RK, Autieri M, Scalia R, Cheng Z, Wang H, Madesh M, Houser SR, Gill DL. Targeted STIM deletion impairs calcium homeostasis, NFAT activation, and growth of smooth muscle. FASEB J 2013; 27: 893-906
38. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, Hogan PG, Lewis RS, Daly M, Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006; 441: 179-185
39. Bohm J, Chevessier F, Maues De Paula A, Koch C, Attarian S, Feger C, Hantai D, Laforet P, Ghorab K, Vallat JM, Fardeau M, Figarella-Branger D, Pouget J, Romero NB, Koch M, Ebel C, Levy N, Krahn M, Eymard B, Bartoli M, Laporte J. Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am J Hum Genet 2013; 92: 271-278
40. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994; 264: 1772-1775
41. Dubowitz V, Sewry CA, Oldfors A. Muscle Biopsy. A Practical Approach. Oxford: Saunders Elsevier, 2013
42. Schroder JM, Hoheneck M, Weis J, Deist H. Ethylene oxide polyneuropathy: clinical follow-up study with morphometric and electron microscopic findings in a sural nerve biopsy. J Neurol 1985; 232: 83-90
43. Fajardo VA, Bombardier E, Vigna C, Devji T, Bloemberg D, Gamu D, Gramolini AO, Quadrilatero J, Tupling AR. Co-expression of SERCA isoforms, phospholamban and sarcolipin in human skeletal muscle fibers. PLoS ONE 2013; 8: e84304
44. Augusto VPC, Campos G. Skeletal muscle fibre types in C57BL6J mice. Braz J Morphol Sci 2004; 21: 89-94
45. Pette D, Staron RS. Myosin isoforms, muscle fiber types, and transitions. Microsc Res Tech 2000; 50: 500-509
46. Funke AD, Esser M, Kruttgen A, Weis J, Mitne-Neto M, Lazar M, Nishimura AL, Sperfeld AD, Trillenberg P, Senderek J, Krasnianski M, Zatz M, Zierz S, Deschauer M. The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case. Clin Genet 2010; 77: 302-303
47. Nishimura AL, Al-Chalabi A, Zatz M. A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum Genet 2005; 118: 499-500
48. Jousset H, Frieden M, Demaurex N. STIM1 knockdown reveals that store-operated Ca2+ channels located close to sarco/endoplasmic Ca2+ ATPases (SERCA) pumps silently refill the endoplasmic reticulum. J Biol Chem 2007; 282: 11456-11464
49. Cusimano V, Pampinella F, Giacomello E, Sorrentino V. Assembly and dynamics of proteins of the longitudinal and junctional sarcoplasmic reticulum in skeletal muscle cells. Proc Natl Acad Sci U S A 2009; 106: 4695-4700
50. Hamalainen N, Pette D. Patterns of myosin isoforms in mammalian skeletal muscle fibres. Microsc Res Tech 1995; 30: 381-389
51. Weis J. Jun, Fos, MyoD1, and myogenin proteins are increased in skeletal muscle fiber nuclei after denervation. Acta Neuropathol 1994; 87: 63-70
52. Weis J, Kaussen M, Calvo S, Buonanno A. Denervation induces a rapid nuclear accumulation of MRF4 in mature myofibers. Dev Dyn 2000; 218: 438-451
53. Lie DC, Weis J. GDNF expression is increased in denervated human skeletal muscle. Neurosci Lett 1998; 250: 87-90
54. Weis J, Lie DC, Ragoss U, Zuchner SL, Schroder JM, Karpati G, Farruggella T, Stahl N, Yancopoulos GD, DiStefano PS. Increased expression of CNTF receptor alpha in denervated human skeletal muscle. J Neuropathol Exp Neurol 1998; 57: 850-857
55. Jackman RW, Kandarian SC. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004; 287: C834-843
56. Stewart CE, Rittweger J. Adaptive processes in skeletal muscle: molecular regulators and genetic influences. J Musculoskelet Neuronal Interact 2006; 6: 73-86
57. Whitehead NP, Yeung EW, Allen DG. Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin Exp Pharmacol Physiol 2006; 33: 657-662
58. Zhao X, Moloughney JG, Zhang S, Komazaki S, Weisleder N. Orai1 mediates exacerbated Ca(2+) entry in dystrophic skeletal muscle. PLoS ONE 2012; 7: e49862
59. Engel WK. Muscle target fibres, a newly recognized sign of denervation. Nature 1961; 191: 389-390
60. Schmitt HP, Volk B. The relationship between target, targetoid, and targetoid/core fibers in severe neurogenic muscular atrophy. J Neurol 1975; 210: 167-181
61. Mrak RE, Saito A, Evans OB, Fleischer S. Autophagic degradation in human skeletal muscle target fibers. Muscle Nerve 1982; 5: 745-753
62. Sandri M. Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophy. Am J Physiol Cell Physiol 2010; 298: C1291-1297
63. Decuypere JP, Kindt D, Luyten T, Welkenhuyzen K, Missiaen L, De Smedt H, Bultynck G, Parys JB. mTOR-controlled autophagy requires intracellular Ca(2+) signaling. PLoS ONE 2013; 8: e61020
64. Smaili SS, Pereira GJ, Costa MM, Rocha KK, Rodrigues L, do Carmo LG, Hirata H, Hsu YT. The role of calcium stores in apoptosis and autophagy. Curr Mol Med 2013; 13: 252-265